Role of Tregs in Cancer Dormancy or Recurrence. - Wikidata - wikimedia - TriplyDB

Role of Tregs in Cancer Dormancy or Recurrence.

Role of Tregs in Cancer Dormancy or Recurrence.

http://www.wikidata.org/entity/Q30244203

about

Nanomedicine and cancer immunotherapy: focus on indoleamine 2,3-dioxygenase inhibitors Foxp3 expression in lymph node metastases in patients with head and neck cancer.Immune Regulatory Function of Tregs.

P2860

Q28818166-B5D5B131-8C72-49C3-B2B5-2BBA5AF768E4 Q47687674-4C08426A-8CD9-4616-843C-9067DAD32826 Q51366875-2308555F-EEE8-4324-8473-CA7A7B336AEF

P2860

Role of Tregs in Cancer Dormancy or Recurrence.

http://www.wikidata.org/entity/Q30244203

description

2016 nî lūn-bûn

@nan

2016 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Role of Tregs in Cancer Dormancy or Recurrence.

@ast

Role of Tregs in Cancer Dormancy or Recurrence.

@en

type

label

Role of Tregs in Cancer Dormancy or Recurrence.

@ast

Role of Tregs in Cancer Dormancy or Recurrence.

@en

prefLabel

Role of Tregs in Cancer Dormancy or Recurrence.

@ast

Role of Tregs in Cancer Dormancy or Recurrence.

@en

P1433

Q30244203-DA8AA070-4C2E-4A0F-9ED1-DCF733D91FE8

P1476

Q30244203-F56C66E9-0A44-4CAA-B46B-F7CECA2C0569

P2093

Q30244203-381E1EB3-C3FD-4D77-BAE8-E93EFABD2AF1

Q30244203-C4FD7209-16A0-456B-B0A6-BA70CB310330

P2860

Q30244203-0042EBF6-42C6-40B2-95DB-F31AD91EB28B

Q30244203-0DDE1354-7E3B-4D27-9668-78F129E9A991

Q30244203-11B6AA2C-E9DB-4D55-9D19-A18DF8DB4BB0

Q30244203-1CAB39EB-BB13-42CE-889D-2859D0E87162

Q30244203-289C95ED-DE8B-4381-8615-AE06E2641A71

Q30244203-3237B85F-72C1-4B4A-BDD6-14311109552B

Q30244203-41BB3062-33DD-46F5-9416-5463DBF91492

Q30244203-41C3EEB7-39A1-43CB-9DD8-85F02D2B1CA9

Q30244203-41EE0A61-CF17-461B-9537-6F7B04EA6176

Q30244203-4605ECC7-489E-4F7C-AE33-B395509D9304

P304

Q30244203-D6E74784-4774-4F5F-B957-A49E1B82FD42

P31

Q30244203-2B11BBC7-45FA-4E77-8587-BD747D0E42B2

P356

Q30244203-E492E859-34DA-429F-9276-28C004EBC481

P433

Q30244203-6CF21882-E50D-445A-8D7C-62223950D966

P478

Q30244203-2887B231-CA8E-4477-9F7A-C1F547D149C8

P577

Q30244203-50E50067-4E83-4DBD-8F89-942B3AD598CF

P698

Q30244203-16A29B9C-68E1-46F1-94BC-C957DEF31577

P356

08820139.2016.1194428

P1433

Immunological Investigations

P1476

Role of Tregs in Cancer Dormancy or Recurrence.

@en

P2093

Masoud H Manjili

http://www.w3.org/2001/XMLSchema#string

Savannah E Butler

http://www.w3.org/2001/XMLSchema#string

P2860

IFN-γ Rα is a key determinant of CD8+ T cell-mediated tumor elimination or tumor escape and relapse in FVB mouse

Cancer immunoediting: from immunosurveillance to tumor escape

The three Es of cancer immunoediting

Regulatory T cells and immune tolerance

High-dose recombinant interleukin 2 therapy for patients with metastatic melanoma: analysis of 270 patients treated between 1985 and 1993

Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.

FOXP3: not just for regulatory T cells anymore.

Tumor escape and progression of HER-2/neu negative breast cancer under immune pressure.

Spectrum of cancer risk among US solid organ transplant recipients.

Malignancy after transplantation.

P304

759-766

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/08820139.2016.1194428

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

45

http://www.w3.org/2001/XMLSchema#string

P577

2016-09-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27603507

http://www.w3.org/2001/XMLSchema#string